Twist Bioscience Corporation (TWST)
NASDAQ: TWST · Real-Time Price · USD
33.68
+0.11 (0.33%)
At close: Aug 1, 2025, 4:00 PM
34.99
+1.31 (3.89%)
After-hours: Aug 1, 2025, 6:52 PM EDT
Twist Bioscience Market Cap
Twist Bioscience has a market cap or net worth of $2.02 billion as of August 1, 2025. Its market cap has decreased by -40.92% in one year.
Market Cap
2.02B
Enterprise Value
1.84B
1-Year Change
-40.92%
Ranking
Category
Stock Price
$33.68
Market Cap Chart
Since October 31, 2018, Twist Bioscience's market cap has increased from $372.54M to $2.02B, an increase of 441.68%. That is a compound annual growth rate of 28.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 2.01B | -27.08% |
| Dec 31, 2024 | 2.76B | 29.75% |
| Dec 29, 2023 | 2.13B | 57.83% |
| Dec 30, 2022 | 1.35B | -64.93% |
| Dec 31, 2021 | 3.84B | -43.70% |
| Dec 31, 2020 | 6.82B | 881.01% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 31, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.37B |
| Johnson & Johnson | 402.99B |
| AbbVie | 344.84B |
| AstraZeneca | 228.08B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 221.54B |
| UnitedHealth Group | 215.69B |
| Novo Nordisk | 211.90B |